Abstract
Calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2) is a serine/threonine-protein kinase, that is involved in maintaining various physiological and cellular processes within the cell that regulate energy homeostasis and cell growth. CaMKK2 regulates glucose metabolism by the activation of downstream kinases, AMP-activated protein kinase (AMPK) and other calcium/calmodulin-dependent protein kinases. Consequently, its deregulation has a role in multiple human metabolic diseases including obesity and cancer. Despite the importance of CaMKK2, its signalling pathways and pathological mechanisms are not completely understood. Recent work has been aimed at broadening our understanding of the biological functions of CaMKK2. These studies have uncovered new interaction partners that have led to the description of new functions that include lipogenesis and Golgi vesicle trafficking. Here, we review recent insights into the role of CaMKK2 in membrane trafficking mechanisms and discuss the functional implications in a cellular context and for disease.
Keywords: calmodulin, Golgi apparatus, protein–serine–threonine kinases, trafficking
Introduction
Calcium (Ca2+) functions as one of the most critical second messengers that regulate a host of downstream signalling events. The Ca2+ sensor calmodulin binds and regulates the activity of target proteins, which include calcium/calmodulin-dependent kinases (CaMK). CaMK kinase (CaMKK) 2 regulates CaMKI and IV by phosphorylating them. In addition, it phosphorylates the α-subunit of AMP-activated protein kinase (AMPK). AMPK is regarded as the master metabolic protein kinase and consequently CAMKK2 has emerged as the primary CaMK participating in the regulation of metabolic homeostasis. CaMKK2 is highly expressed in the hypothalamus and plays a fundamental role in whole-body energy homeostasis and glucose metabolism and is associated with many metabolic diseases. It is overexpressed in and promotes prostate, breast, liver, ovarian and gastric cancer [1–5]. In this review, we discuss research on CaMKK2 that contextualises its functions that are associated with intracellular membrane trafficking.
Structural and functional insights to CaMKK2
CaMKK2 (CAMKKβ) is a calcium/calmodulin-dependent serine/threonine-protein kinase [6]. The sequence homology of CaMKK2 with family members CaMKK1 (CAMKKa), CaMKI and CaMKIV are high. For example, CaMKK1 and CaMKK2 show a 70% amino acid identity [6]. CaMKK2 is composed of an N-terminal regulatory domain containing three phosphorylation sites (serines) for GSK3, CDK5 and PKA (Figure 1A). A central catalytic domain is immediately followed by a domain containing the regulatory and calmodulin-binding sequences [7]. CaMKK2 has a significant kinase activity at steady state, but its activity is significantly increased by an elevation in intracellular Ca2+ and binding of calcium–calmodulin (CaM) [6–8]. The interaction of CaMKK2 with CaM releases the binding of the autoinhibitory region and leads to the activation of the enzymatic activity [9,10]. Its autonomous activity is dependent on the autophosphorylation of Thr482 in the C-terminal regulatory domain, while the calmodulin-dependent activity is dependent on the phosphorylation of serine residues in the N-terminal regulatory domain [11]. The catalytic domain is composed of two lobes that are connected by a flexible linker: the ATP-binding pocket and the substrate-binding domain [12]. CaMKK2 has seven isoforms that differ in their domain composition and ability to autophosphorylate and phosphorylate downstream targets (Figure 1A). It is mainly the longest isoform that is well characterised (588 aa, 64.7 kDa). Based on the sequences (Figure 1A), there may be differences among the isoforms in relation to kinase activity, autoinhibition and autophosphorylation [1,13].
The active CaMKK2 directly phosphorylates downstream kinases CaMKI, CAMKIV and AMPK, which regulates cellular metabolism. AMPK is central in the regulation of energy homeostasis because it acts as an energy sensor. The conversion of ATP to AMP/ADP due to energy stress activates the kinase activity of AMPK, phosphorylating downstream targets that control cell proliferation pathways, and transcription and translation factors. In turn, processes like autophagy and catabolism of fatty acids and glucose are increased, while the synthesis of macromolecules like proteins and cholesterol is decreased. CaMKIV activation results in the activation of transcriptional programmes that regulate the expression of proteins that mediate cell growth and metabolism [2,14].
Further functional insights for CaMKK2 arise from studies investigating the localisation of the enzyme. Its localisation is predominantly cytosolic as determined by immunocytochemistry and biochemical fractionation experiments [15–17]. However, it has also been shown to localise to the nucleus and facilitate transcriptional regulation in prostate and ovarian epithelial cells [8,18]. In ovarian cancer cells, this translocation is induced by epidermal growth factor (EGF) stimulation [8]. In addition to its cytosolic localisation, an experiment using subcellular fractionation of endothelial cells showed a prominent association of CaMKK2 with the endoplasmic reticulum (ER) and mitochondria [15]. While more research is required to fully understand the recruitment and function of CaMKK2 at the ER and mitochondria it is interesting in the context of recent studies showing that AMPK, considered to be a mainly cytosolic protein, under some circumstances is activated on the surface of the lysosome by LKB1 and at the ER and Golgi by CaMKK2 [19–22]. Thus, illustrating the necessity to define protein–protein interactions and their spatial location within cells in order to develop a complete picture of the biological functions of CAMKK2 and other kinases in relation to signalling and metabolism.
The CaMKK2 interactome and substrates
The interactome of CaMKK2 has been determined experimentally from co-immunoprecipitation of EGFP-tagged CaMKK2 in HEK293 cells and from immunoprecipitation of endogenous CaMKK2 from cell lines [23–26]. Among the cellular ontologies that are enriched in the interactome of CaMKK2 we find focal adhesions, lipid synthesising and metabolising enzymes, translational regulators, membrane trafficking and vesicle-associated proteins (Figure 1B). This indicates that we have a limited understanding of the function of CaMKK2, and there are additional pathways beyond cellular signalling that are regulated by CaMKK2. One example of a CaMKK2-binding protein that was identified by mass spectrometry and has expanded our understanding of the functional repertoire of CaMKK2 is fatty acid synthase (FASN) [24]. Functional studies show that the down-regulation of CaMKK2 by microRNA and in knockout mice generates a significant increase in lipid accumulation along with increased levels of FASN and SREBP1c, indicating either a direct or indirect relationship between FASN and CaMKK2 signalling [27,28]. Mapping of the kinome of CaMKK2 using quantitative phospho-proteomics of cells treated with the inhibitor STO-609 also enhance our understanding of the function of the protein. Recent studies in gastric cancer cell lines identified several potential novel substrates of CaMKK2 [29,30]. Novel CaMKK2 substrates include kinases in the ephrin receptor signalling pathway, EGF signalling and the MAPK pathway. Furthermore, proteins that are hypo-phosphorylated in cells treated with STO-609 associate with focal adhesions, plasma membrane, cytosol, vesicle membrane and the Golgi apparatus to mention a few [29]. The main limitation of these studies is the poor specificity of the inhibitor STO-609, but nevertheless adds significant information to our understanding of the complexity of CaMKK2 functions [10]. Together, the interactome and kinome of CaMKK2 implicate that this kinase has functions associated with membranes and membrane trafficking.
Regulation of intracellular membrane trafficking by calcium/calmodulin
Cells rapidly respond to their physical environment, energy demands and signalling molecules. A key part of this response is the use of vesicle trafficking between organelles and in the secretory pathway. These trafficking pathways are important for the delivery of newly synthesised proteins and lipids to the correct target location, and in addition, orchestrate the homeostasis of these organelles. Here, we will discuss their regulation by CaM. The main calcium stores in the mammalian cell are the ER, Golgi and the lysosome [31]. Calcium plays a well-established role in vesicle trafficking and CaM is emerging as an additional regulatory complex [32,33]. The direct involvement of CaM in endocytosis has recently been demonstrated through experiments in the calyx of Held nerve terminals in CaM knockout mice [34]. The effectors of CaM that regulate endocytosis include calcineurin, a protein phosphatase, CaMKK2 and protein kinase C (PKC) [34–36]. Vesicle trafficking between the ER and Golgi is regulated by calcium through mechanisms that include Ca2+ channels in the ER [31]. Vesicle formation is tightly regulated by the recruitment of membrane-binding and structural proteins that together form a coat of a defined size that envelope the membrane and create a bud that can be pinched off from the organelle. There are classes of coat proteins that facilitate the formation of vesicles from different organelles. For example, COPI and COPII, on the Golgi and ER mediate the trafficking of cargo in the retrograde and anterograde direction. Disruption of Ca2+ signalling abrogates coat recruitment and vesicle formation for both anterograde and retrograde vesicle trafficking between these two organelles [37–40]. In this context, it is important to mention that the Golgi is a Ca2+ storage organelle with a concentration gradient that ranges from 300 µM in the cis-Golgi to 100 µM in the trans-Golgi [31]. A transient localised increase in Ca2+ concentration can be sensed by CaM (Kd = 0.5–5 µM), which results in a conformational change and interaction with target proteins [41]. Experiments using cell-free assays with purified organelles demonstrate that the calcium chelator BAPTA or CaM inhibitors strongly inhibit Golgi vesicle transport [42]. The addition of BAPTA to a cell-free system showed a distinct loss of coated vesicles subsequent to coat assembly, demonstrating that calcium or a calcium-dependent sensor stabilises the COPI coat at the Golgi membrane [39]. Together with the fact that Golgi calcium stores are significant and contribute to subcellular signalling events highlight the significance of calcium and CaM in regulating Golgi vesicle trafficking [39,43,44]. The calcium sensors and CaM-dependent effectors remain not well understood and more research is, therefore, required in this area.
Golgi membrane trafficking
The Golgi supports cellular functions such as intracellular vesicle trafficking, protein secretion, regulation of ion homeostasis and glycosylation [45]. It has an essential role as an intracellular signalling platform and a stress sensor that facilitates intracellular communication that impact on cell metabolism, death, migration and proliferation [46–50]. To sustain the function and organisation of Golgi cisternae and its resident proteins it is important that the flux of anterograde and retrograde vesicle trafficking is in balance [51,52]. Three types of coated vesicles have been described in association with the Golgi; COPI, COPII and clathrin [53–55] (Figure 2). Clathrin-coated vesicles bud from the trans-Golgi and mainly transport enzymes to the lysosome [56]. COPII-coated vesicle mainly transport cargo from the ER to the Golgi, while COPI-coated vesicles facilitate retrograde traffic from the Golgi to the ER and within the Golgi (Figure 2). Vesicle formation is modulated by the conserved oligomeric Golgi (COG) complex and small nucleotide-binding proteins of the Rab and Arf families that facilitate the recruitment of coatomer to the membrane [57]. The interactions of the coatomers with these modulators are important for protein stabilisation and vesicle trafficking [58]. Together, this illustrates the close relationship between modulating proteins and the impact on protein stability and functional Golgi vesicle trafficking. The Golgi is organised in stacks of cisternae with a cis- and a trans-face. These mini-stacks are linked together in a ribbon structure and can undergo dynamic changes resulting in compaction, dispersal, disassembly of the ribbon or dispersal of both the ribbon and mini-stacks [59]. Golgi morphology may change due to the dispersal of one compartment, for example, the trans-Golgi cisternae. Golgi morphology is regulated by kinases and phosphatases, making it suited to respond to and co-ordinate cell signalling and processes during cancer and stress conditions [60]. Pathological conditions like these may result in the loss of the Golgi ribbon, which leads to a dispersed appearance [59]. For example, loss of α-COP, a COPI coatomer or phosphorylation of Rab7 results in a dispersed Golgi morphology and increased area of the trans-Golgi [61,62]. An altered Golgi morphology is often observed when proteins linking the cisternae or the ribbon are depleted or the interaction with the cytoskeleton is lost, but is also regulated by Rab GTPases [60,63–66].
Given the central role of the Golgi and Golgi-ER trafficking in supporting organelle biogenesis and enzyme activity, it will also play an important role in responding and adapting to metabolic and proteotoxic stress. The ER responds through the unfolded protein response which can enhance protein folding capacity but also autophagic flux. This also leads to significant changes in the trafficking of vesicles between the Golgi and the ER and in protein secretion. To support these changes Golgi proteins are up-regulated and some of these are structural or mediators of vesicle trafficking [67–70]. Recent studies have linked the Golgi apparatus as an organelle able to control mTOR signalling directly, in addition to the tight regulation of mTOR signalling and cell proliferation by the lysosome [71–73]. One of the studies discovered part of ER-to-Golgi trafficking machinery, Rab1A, to be an independent controller of mTORC1 promoting cell proliferation [74]. We recently undertook a study to learn more about the role of CaMKK2 in prostate cancer which commenced with a characterisation of CaMKK2 protein interactions and led us to investigate effects on Golgi trafficking and lysosome function in cancer cell proliferation.
CaMKK2 as a regulator of membrane trafficking events
Recently, a few studies have shown an association of CaMKK2 with membrane trafficking events; endocytosis and COPI trafficking (Figure 3) [25,75]. A genome-wide screen of kinases that regulate transferrin internalisation identified CaMKK2 as a regulator of endocytosis [36]. Further studies show that a loss of CaMKK2 expression leads to impaired transferrin internalisation in HepG2, LNCaP and HeLa cell lines, which results in reduced intracellular iron content and impaired glucose metabolism and glycolysis [15,25,36,76]. Whether CaMKK2 directly regulates adaptor or accessory proteins in clathrin-mediated endocytosis, the endocytic pathway for the Transferrin receptor, is not known. In addition, CaMKK2 associates with the Cav1.2 calcium channel at caveolae on the plasma membrane where it phosphorylates CaMKI upstream of the transcription factor CREB, which results in the regulation of chemotaxis in vascular myocytes [75]. This illustrates the significance of membrane-associated localisation and temporal Ca2+ activation of CaMKK2. Co-immunoprecipiation studies have shown that CaMKK2 associates with the δ-COP coat protein, a part of the COPI vesicle coat that mediates Golgi-ER trafficking [24,25]. This observation was further validated by demonstrating that the CaMKK2–Gemin4 complex efficiently enriched COPI coat proteins from a cell lysate [25]. Gemin4 is a part of multiple protein complexes that are involved in COPI/coatomer formation, autophagy, assembly of small nuclear ribonucleoproteins and trafficking of ribonucleoproteins. The COPI coat is composed from seven proteins that assemble into triad units that are recruited to the membrane together and interact with up to four triads to build the lattice of the coat [77,78]. The flexible linker regions of δ-COP and α-COP are important for cross-linking the coatomer triads to stabilise the lattice. The binding of ER retrieval signals by α-, β- and δ-COP further facilitates molecular rearrangements that stabilises the COPI coat [53,77,79–82]. Knockdown of CaMKK2 in the prostate cancer cell line LNCaP results in a significant reduction in δ-COP protein levels, along with a reduction in α-COP [25]. Furthermore, inhibition of the kinase activity of CaMKK2 reduces the levels of δ-COP to similar levels [25]. This could be due to transcriptional changes, instability of the protein complex due to loss of a direct protein interaction or regulation by phosphorylation, consequently more experiments are required to elucidate this mechanism. The gene encoding δ-COP is transcriptionally regulated by the androgen receptor, which makes it more likely to be due to protein stability. The reduction in protein expression of coatomer, in particular δ-COP that cross-links the coat proteins, would be expected to negatively impact on the stability of COPI coats and the productive vesicle trafficking events in CaMKK2 knockdown cells, resulting in impaired membrane trafficking and organelle homeostasis. The study observed an enlarged Golgi, ER stress, impaired lysosomal acidification and reduced clathrin-mediated transferrin endocytosis [25]. These membrane trafficking pathways are interconnected due to the topological relationship between these organelles. A loss of transferrin uptake can be due either to a loss of assembly of the clathrin coat at the plasma membrane or a loss of intracellular membrane trafficking. For example, a reduction in β1-COP expression results in a reduction in transferrin uptake [83]. Furthermore, loss of membrane homeostasis in the ER-Golgi also impacts on the lysosomal maturation and biogenesis [84–87]. In cells where CaMKK2 expression is knocked down the acidification of lysosomes is significantly reduced, the sensitivity to BafilomycinA treatment impaired and the processing of the lysosomal protein CathepsinD reduced [25]. This indicates that membrane trafficking through the Golgi is slowed, which creates an unbalance in the membrane trafficking of the endomembrane compartments. The COPI coatomer complex, and in particular δ-COP, is not only required for retrograde vesicle trafficking but also essential for productive autophagy [88–90]. Autophagy is an important mechanism in cancer cells that are under metabolic stress, which produces energy and amino acids necessary for cell survival. Experiments in multiple cancer cells show that COPI vesicle trafficking is not only facilitates Golgi to ER trafficking but also mediates traffic within the ER and to lysosomes and regulates autophagy [73,88,91–94]. The loss of COPI coat components results in impaired cell survival and an increased ER stress, which may be due to the disrupted trafficking leading to an accumulation of proteins in the ER and an activation of the unfolded protein response [88]. This phenotype is also observed upon loss of CaMKK2 expression in a prostate cancer cell line [25], suggesting that the observed accompanying loss of COPI coat proteins may cause of the impaired autophagy and ER stress observed thus further illustrating the significant role of CaMKK2 in Golgi vesicle trafficking and cell survival.
Implications for our understanding of how CaMKK2 contributes to cancer progression
CaMKK2 is known to be significantly overexpressed in many cancers, including prostate, glioblastoma, liver and ovarian cancer [2,8,18,95,96]. Given the significant literature on the role of AMPK and CAMKIV activities on metabolic regulation, and their established status as CaMKK2 substrates, many of the biological effects of CaMKK2 on cancer have been attributed to this relationship. Our recent study suggests that there are fundamental roles for CaMKK2 as a regulator of membrane trafficking that can have equally profound effects on the metabolic and hence the proliferative capacity of cancer cells [25,97,98]. We know from the work of Michael White and others that COPI coatomer expression and retrograde Golgi trafficking sustains lysosomal activity and metabolic function in LKB1-mutant lung cancers [88,99]. We also know that increased COPI coatomer subunit expression is a cancer marker [88,100]. Our work suggests that CaMKK2 activity supports the same tumorigenic biology. Translationally future studies will need to address whether CaMKK2 activity or expression is a hallmark of the same coatomer-dependent sub-types of cancer and biologically future studies will need to determine what the CaMKK2 substrates are that regulate COPI coatomer subunit expression or stability. Finally given the inability to rescue defects induced by targeting CaMKK2 with either CAMKIV overexpression in liver cancer or with AMPK activators in prostate cancer [28], it will be important to determine whether COPI coatomer subunit overexpression can rescue defects in these or other disease settings. Cell biology and close attention to the spatial context in which enzymes function can provide new insights into the functions of long-studied kinases in health and disease.
Conclusion
Our understanding of the functions of CaMKK2 in health and disease has progressed significantly recently through studies of the interactome, kinome, development of new inhibitors and the study of phenotypes and mechanisms in knockdown cells and knockout animals [1,25,28,75,88,101–105]. We have started to uncover new ways in which CaMKK2 regulates energy homeostasis, cell proliferation and migration. In doing so we find that CaMKK2 associated with membranes; plasma membrane, autophagic vacuoles, Golgi apparatus and peroxisomes; regulates novel mechanisms that are relevant for our understanding of CaMKK2 in disease biology and helps us to interpret the effects of novel CaMKK2 inhibitors. We are just starting to appreciate the various functions that CaMKK2 has and how some of these may be cell-type specific and contribute to disease biology [25,75,103].
Perspectives
Importance of the field: The Golgi apparatus is central to fundamental cellular processes such as protein trafficking, cell proliferation and ion homeostasis. It is, therefore, critical to understand the modulators that regulate the vesicle trafficking that maintains its morphology and function. CaMKK2 is a novel modulator of Golgi vesicle trafficking that is overexpressed in several diseases.
Current thinking: Golgi-mediated cell communication is important for the regulation of cell metabolism, migration and proliferation. Modulators of Golgi vesicle trafficking are important for stabilising the coat components and modulating vesicle trafficking and cellular functions linked to cancer development.
Future direction: Translational research studies will be important to identify sub-types of cancers that are dependent on CaMKK2 and COPI trafficking. The molecular mechanisms that contribute to the stabilisation of coatomer should also be actively investigated as these appear to promote pro-proliferative mechanisms in cancer.
Abbreviations
- AMPK
AMP-activated protein kinase
- Ca2+
calcium
- CaM
calcium and calmodulin
- CaMKK2
calcium/calmodulin-dependent protein kinase kinase 2
- COG
conserved oligomeric Golgi
- EGF
epidermal growth factor
- ER
endoplasmic reticulum
- FASN
fatty acid synthase
- PKC
protein kinase C
Competing Interests
The authors declare that there are no competing interests associated with the manuscript.
Funding
We did not receive funding towards this work.
Open Access
Open access for this article was enabled by the participation of Queen's University Belfast in an all-inclusive Read & Publish agreement with Portland Press and the Biochemical Society under a transformative agreement with JISC.
Author Contribution
All authors contributed to the writing and approved the final version of the manuscript.
References
- 1.Pulliam, T.L., Goli, P., Awad, D., Lin, C., Wilkenfeld, S.R. and Frigo, D.E. (2022) Regulation and role of CAMKK2 in prostate cancer. Nat. Rev. Urol. 19, 367–380 10.1038/s41585-022-00588-z [DOI] [PubMed] [Google Scholar]
- 2.Lin, F., Marcelo, K.L., Rajapakshe, K., Coarfa, C., Dean, A., Wilganowski, N.et al. (2015) The camKK2/camKIV relay is an essential regulator of hepatic cancer. Hepatology 62, 505–520 10.1002/hep.27832 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Liu, D., Wang, H., Han, B., Meng, X., Chen, M., Yang, D.et al. (2016) CAMKK2, regulated by promoter methylation, is a prognostic marker in diffuse gliomas. CNS Neurosci. Ther. 22, 518–524 10.1111/cns.12531 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Gocher, A.M., Azabdaftari, G., Euscher, L.M., Dai, S., Karacosta, L.G., Franke, T.F.et al. (2017) Akt activation by Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) in ovarian cancer cells. J. Biol. Chem. 292, 14188–14204 10.1074/jbc.m117.778464 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Subbannayya, Y., Syed, N., Barbhuiya, M.A., Raja, R., Marimuthu, A., Sahasrabuddhe, N.et al. (2015) Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma. Cancer Biol. Ther. 16, 336–345 10.4161/15384047.2014.972264 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Anderson, K.A., Means, R.L., Huang, Q.-H., Kemp, B.E., Goldstein, E.G.. Selbert, M.A., et al. (1998) Components of a calmodulin-dependent protein kinase cascade molecular cloning, functional characterization and cellular localization of Ca2+/calmodulin-dependent protein kinase kinase β. J. Biol. Chem. 273, 31880–31889 10.1074/jbc.273.48.31880 [DOI] [PubMed] [Google Scholar]
- 7.Tokumitsu, H., Iwabu, M., Ishikawa, Y. and Kobayashi, R. (2001) Differential regulatory mechanism of Ca2+/calmodulin-dependent protein kinase kinase isoforms. Biochemistry 40, 13925–13932 10.1021/bi010863k [DOI] [PubMed] [Google Scholar]
- 8.Dai, S., Venturini, E., Yadav, S., Lin, X., Clapp, D., Steckiewicz, M.et al. (2022) Calcium/calmodulin-dependent protein kinase kinase 2 mediates pleiotropic effects of epidermal growth factor in cancer cells. Biochim. Biophys. Acta – Mol. Cell Res. 1869, 119252 10.1016/j.bbamcr.2022.119252 [DOI] [PubMed] [Google Scholar]
- 9.Tokumitsu, H., Muramatsu, M., Ikura, M. and Kobayashi, R. (2000) Regulatory mechanism of Ca2+/calmodulin-dependent protein kinase kinase. J. Biol. Chem. 275, 20090–20095 10.1074/jbc.m002193200 [DOI] [PubMed] [Google Scholar]
- 10.Tokumitsu, H. and Sakagami, H. (2022) Molecular mechanisms underlying Ca2+/calmodulin-dependent protein kinase kinase signal transduction. Int. J. Mol. Sci. 23, 11025 10.3390/ijms231911025 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Racioppi, L. and Means, A.R. (2012) Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology. J. Biol. Chem. 287, 31658–31665 10.1074/jbc.r112.356485 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Swulius, M.T. and Waxham, M.N. (2008) Ca2+/calmodulin-dependent protein kinases. Cell Mol. Life Sci. 65, 2637 10.1007/s00018-008-8086-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hsu, L.-S., Chen, G.-D., Lee, L.-S., Chi, C.-W., Cheng, J.-F. and Chen, J.-Y. (2001) Human Ca2+/calmodulin-dependent protein kinase kinase β gene encodes multiple isoforms that display distinct kinase activity. J. Biol. Chem. 276, 31113–31123 10.1074/jbc.m011720200 [DOI] [PubMed] [Google Scholar]
- 14.Marcelo, K.L., Means, A.R. and York, B. (2016) The Ca(2+)/calmodulin/CaMKK2 axis: nature's metabolic CaMshaft. Trends Endocrinol. Metab. 27, 706–718 10.1016/j.tem.2016.06.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sabbir, M.G., Taylor, C.G. and Zahradka, P. (2020) Hypomorphic CAMKK2 in EA.hy926 endothelial cells causes abnormal transferrin trafficking, iron homeostasis and glucose metabolism. Biochim. Biophys. Acta – Mol. Cell Res. 1867, 118763 10.1016/j.bbamcr.2020.118763 [DOI] [PubMed] [Google Scholar]
- 16.Karacosta, L.G., Foster, B.A., Azabdaftari, G., Feliciano, D.M. and Edelman, A.M. (2012) A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression. J. Biol. Chem. 287, 24832–24843 10.1074/jbc.m112.370783 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Nakamura, Y., Okuno, S., Kitani, T., Otake, K., Sato, F. and Fujisawa, H. (2001) Immunohistochemical localization of Ca2+/calmodulin-dependent protein kinase kinase β in the rat central nervous system. Neurosci. Res. 39, 175–188 10.1016/s0168-0102(00)00209-1 [DOI] [PubMed] [Google Scholar]
- 18.Massie, C.E., Lynch, A., Ramos-Montoya, A., Boren, J., Stark, R., Fazli, L.et al. (2011) The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J. 30, 2719–2733 10.1038/emboj.2011.158 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Chauhan, A.S., Zhuang, L. and Gan, B. (2020) Spatial control of AMPK signaling at subcellular compartments. Crit. Rev. Biochem. Mol. 55, 17–32 10.1080/10409238.2020.1727840 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Zhang, C.-S., Jiang, B., Li, M., Zhu, M., Peng, Y., Zhang, Y.-L.et al. (2014) The lysosomal v-ATPase-ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab. 20, 526–540 10.1016/j.cmet.2014.06.014 [DOI] [PubMed] [Google Scholar]
- 21.Chauhan, A.S., Liu, X., Jing, J., Lee, H., Yadav, R.K., Liu, J.et al. (2019) STIM2 interacts with AMPK and regulates calcium-induced AMPK activation. FASEB J. 33, 2957–2970 10.1096/fj.201801225r [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Mao, L., Li, N., Guo, Y., Xu, X., Gao, L., Xu, Y.et al. (2013) AMPK phosphorylates GBF1 for mitotic Golgi disassembly. J. Cell Sci. 126, 1498–1505 10.1242/jcs.121954 [DOI] [PubMed] [Google Scholar]
- 23.Huttlin, E.L., Bruckner, R.J., Navarrete-Perea, J., Cannon, J.R., Baltier, K., Gebreab, F.et al. (2021) Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell 184, 3022–3040.e28 10.1016/j.cell.2021.04.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Behrends, C., Sowa, M.E., Gygi, S.P. and Harper, J.W. (2010) Network organization of the human autophagy system. Nature 466, 68–76 10.1038/nature09204 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Stewart, L.M., Gerner, L., Rettel, M., Stein, F., Burrows, J.F., Mills, I.G.et al. (2021) CaMKK2 facilitates Golgi-associated vesicle trafficking to sustain cancer cell proliferation. Cell Death Dis. 12, 1040 10.1038/s41419-021-04335-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Buljan, M., Ciuffa, R., van Drogen, A., Vichalkovski, A., Mehnert, M., Rosenberger, G.et al. (2020) Kinase interaction network expands functional and disease roles of human kinases. Mol. Cell 79, 504–520.e9 10.1016/j.molcel.2020.07.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wang, Y.-Z., Lu, J., Li, Y.-Y., Zhong, Y.-J., Yang, C.-F., Zhang, Y.et al. (2021) microRNA-378b regulates ethanol-induced hepatic steatosis by targeting CaMKK2 to mediate lipid metabolism. Bioengineered 12, 12659–12676 10.1080/21655979.2021.2003677 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Penfold, L., Woods, A., Muckett, P., Nikitin, A.Y., Kent, T.R., Zhang, S.et al. (2018) CAMKK2 promotes prostate cancer independently of AMPK via increased lipogenesis. Cancer Res. 78, 6747–6761 10.1158/0008-5472.can-18-0585 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Najar, M.A., Arefian, M., Sidransky, D., Gowda, H., Prasad, T.S.K., Modi, P.K., et al. (2022) Tyrosine phosphorylation profiling revealed the signaling network characteristics of CAMKK2 in gastric adenocarcinoma. Front. Genet. 13, 854764 10.3389/fgene.2022.854764 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Najar, M.A., Modi, P.K., Ramesh, P., Sidransky, D., Gowda, H., Prasad, T.S.K., et al. (2021) Molecular profiling associated with calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2)-mediated carcinogenesis in gastric cancer. J. Proteome Res. 20, 2687–2703 10.1021/acs.jproteome.1c00008 [DOI] [PubMed] [Google Scholar]
- 31.Sargeant, J. and Hay, J.C. (2022) Ca2+ regulation of constitutive vesicle trafficking. Fac Rev. 11, 6 10.12703/r/11-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Elíes, J., Yáñez, M., Pereira, T.M.C., Gil-Longo, J., MacDougall, D.A. and Campos-Toimil, M. (2019) Calcium signaling. Adv. Exp. Med. Biol. 1131, 183–213 10.1007/978-3-030-12457-1_8 [DOI] [PubMed] [Google Scholar]
- 33.Martens, S. and McMahon, H.T. (2011) Chapter 6 C2 domains and membrane fusion. Curr. Top. Membr. 68, 141–159 10.1016/b978-0-12-385891-7.00006-4 [DOI] [PubMed] [Google Scholar]
- 34.Jin, Y.-H., Wu, X.-S., Shi, B., Zhang, Z., Guo, X., Gan, L.et al. (2019) Protein kinase C and calmodulin serve as calcium sensors for calcium-stimulated endocytosis at synapses. J. Neurosci. 39, 9478–9490 10.1523/jneurosci.0182-19.2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Clayton, E.L., Anggono, V., Smillie, K.J., Chau, N., Robinson, P.J. and Cousin, M.A. (2009) The phospho-dependent dynamin-syndapin interaction triggers activity-dependent bulk endocytosis of synaptic vesicles. J. Neurosci. 29, 7706–7717 10.1523/jneurosci.1976-09.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Pelkmans, L., Fava, E., Grabner, H., Hannus, M., Habermann, B., Krausz, E.et al. (2005) Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 436, 78–86 10.1038/nature03571 [DOI] [PubMed] [Google Scholar]
- 37.Cho, H.J. and Mook-Jung, I. (2020) Amyloid beta regulates ER exit sites formation through O-GlcNAcylation triggered by disrupted calcium homeostasis. Biol. Cell 112, 439–451 10.1111/boc.201900062 [DOI] [PubMed] [Google Scholar]
- 38.Cho, H.J. and Mook-Jung, I. (2018) O-GlcNAcylation regulates endoplasmic reticulum exit sites through Sec31A modification in conventional secretory pathway. FASEB J. 32, 4641–4657 10.1096/fj.201701523r [DOI] [PubMed] [Google Scholar]
- 39.Ahluwalia, J.P., Topp, J.D., Weirather, K., Zimmerman, M. and Stamnes, M. (2001) A role for calcium in stabilizing transport vesicle coats. J. Biol. Chem. 276, 34148–34155 10.1074/jbc.m105398200 [DOI] [PubMed] [Google Scholar]
- 40.Bentley, M., Nycz, D.C., Joglekar, A., Fertschai, I., Malli, R., Graier, W.F.et al. (2010) Vesicular calcium regulates coat retention, fusogenicity, and size of pre-Golgi intermediates. Mol. Biol. Cell 21, 1033–1046 10.1091/mbc.e09-10-0914 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Chin, D. and Means, A.R. (2000) Calmodulin: a prototypical calcium sensor. Trends Cell Biol. 10, 322–328 10.1016/s0962-8924(00)01800-6 [DOI] [PubMed] [Google Scholar]
- 42.Porat, A. and Elazar, Z. (2000) Regulation of intra-Golgi membrane transport by calcium. J. Biol. Chem. 275, 29233–29237 10.1074/jbc.m005316200 [DOI] [PubMed] [Google Scholar]
- 43.Zha, X., Chandra, S., Ridsdale, A.J. and Morrison, G.H. (1995) Golgi apparatus is involved in intracellular Ca2+ regulation in epithelial LLC-PK1 cells. Am. J. Physiol. 268, C1133–C1140 10.1152/ajpcell.1995.268.5.c1133 [DOI] [PubMed] [Google Scholar]
- 44.Zha, X. and Morrison, G.H. (1995) Ion microscopy evidence that La3+ releases Ca2+ from Golgi complex in LLC-PK1 cells. Am. J. Physiol. 269, C923–C928 10.1152/ajpcell.1995.269.4.c923 [DOI] [PubMed] [Google Scholar]
- 45.Galenkamp, K.M.O., Sosicka, P., Jung, M., Recouvreux, M.V., Zhang, Y., Moldenhauer, M.R.et al. (2020) Golgi acidification by NHE7 regulates cytosolic pH homeostasis in pancreatic cancer cells. Cancer Discov. 10, 822–835 10.1158/2159-8290.cd-19-1007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Martins, M., Fernandes, A.S. and Saraiva, N. (2022) GOLGI: cancer cell fate control. Int. J. Biochem. Cell Biol. 145, 106174 10.1016/j.biocel.2022.106174 [DOI] [PubMed] [Google Scholar]
- 47.Hassinen, A., Khoder-Agha, F., Khosrowabadi, E., Mennerich, D., Harrus, D., Noel, M.et al. (2019) A Golgi-associated redox switch regulates catalytic activation and cooperative functioning of ST6Gal-I with B4GalT-I. Redox Biol. 24, 101182 10.1016/j.redox.2019.101182 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Rizzo, R., Russo, D., Kurokawa, K., Sahu, P., Lombardi, B., Supino, D.et al. (2021) Golgi maturation-dependent glycoenzyme recycling controls glycosphingolipid biosynthesis and cell growth via GOLPH3. EMBO J. 40, e107238 10.15252/embj.2020107238 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Carrara, G., Saraiva, N., Parsons, M., Byrne, B., Prole, D.L., Taylor, C.W.et al. (2015) Golgi anti-apoptotic proteins are highly conserved ion channels that affect apoptosis and cell migration. J. Biol. Chem. 290, 11785–11801 10.1074/jbc.m115.637306 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Wenzel, E.M., Elfmark, L.A., Stenmark, H. and Raiborg, C. (2022) ER as master regulator of membrane trafficking and organelle function. J. Cell Biol. 221, e202205135 10.1083/jcb.202205135 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Bonifacino, J.S. and Lippincott-Schwartz, J. (2003) Coat proteins: shaping membrane transport. Nat. Rev. Mol. Cell Biol. 4, 409–414 10.1038/nrm1099 [DOI] [PubMed] [Google Scholar]
- 52.Saftig, P. and Klumperman, J. (2009) Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat. Rev. Mol. Cell Biol. 10, 623–635 10.1038/nrm2745 [DOI] [PubMed] [Google Scholar]
- 53.Noble, A.J. and Stagg, S.M. (2015) COPI gets a fancy new coat. Science 349, 142–143 10.1126/science.aac6537 [DOI] [PubMed] [Google Scholar]
- 54.Robinson, M.S. (2015) Forty years of clathrin-coated vesicles. Traffic 16, 1210–1238 10.1111/tra.12335 [DOI] [PubMed] [Google Scholar]
- 55.Dell'Angelica, E.C. and Bonifacino, J.S. (2019) Coatopathies: genetic disorders of protein coats. Annu. Rev. Cell Dev. Biol. 35, 131–168 10.1146/annurev-cellbio-100818-125234 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Tang, T., Yang, Z., Wang, D., Yang, X., Wang, J., Li, L.et al. (2020) The role of lysosomes in cancer development and progression. Cell Biosci. 10, 131 10.1186/s13578-020-00489-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Saito, K., Maeda, M. and Katada, T. (2017) Regulation of the Sar1 GTPase cycle is necessary for large cargo secretion from the endoplasmic reticulum. Front. Cell Dev. Biol. 5, 75 10.3389/fcell.2017.00075 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Blackburn, J.B., D'Souza, Z. and Lupashin, V.V. (2019) Maintaining order: COG complex controls Golgi trafficking, processing, and sorting. FEBS Lett. 593, 2466–2487 10.1002/1873-3468.13570 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Makhoul, C., Gosavi, P. and Gleeson, P.A. (2019) Golgi dynamics: the morphology of the mammalian Golgi apparatus in health and disease. Front. Cell Dev. Biol. 7, 112 10.3389/fcell.2019.00112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Chia, J., Goh, G., Racine, V., Ng, S., Kumar, P. and Bard, F. (2012) RNAi screening reveals a large signaling network controlling the Golgi apparatus in human cells. Mol. Syst. Biol. 8, 629 10.1038/msb.2012.59 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Custer, S.K., Foster, J.N., Astroski, J.W. and Androphy, E.J. (2019) Abnormal Golgi morphology and decreased COPI function in cells with low levels of SMN. Brain Res. 1706, 135–146 10.1016/j.brainres.2018.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Fujimoto, T., Kuwahara, T., Eguchi, T., Sakurai, M., Komori, T. and Iwatsubo, T. (2018) Parkinson's disease-associated mutant LRRK2 phosphorylates Rab7L1 and modifies trans-Golgi morphology. Biochem. Biophys. Res. Commun. 495, 1708–1715 10.1016/j.bbrc.2017.12.024 [DOI] [PubMed] [Google Scholar]
- 63.Kelly, E.E., Giordano, F., Horgan, C.P., Jollivet, F., Raposo, G. and McCaffrey, M.W. (2012) Rab30 is required for the morphological integrity of the Golgi apparatus. Biol. Cell 104, 84–101 10.1111/boc.201100080 [DOI] [PubMed] [Google Scholar]
- 64.Liu, S., Hunt, L. and Storrie, B. (2013) Rab41 is a novel regulator of Golgi apparatus organization that is needed for ER-to-Golgi trafficking and cell growth. PLoS One 8, e71886 10.1371/journal.pone.0071886 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Liu, S. and Storrie, B. (2015) Chapter one how Rab proteins determine Golgi structure. Int. Rev. Cel Mol. Biol. 315, 1–22 10.1016/bs.ircmb.2014.12.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Makhoul, C., Gosavi, P., Duffield, R., Delbridge, B., Williamson, N.A. and Gleeson, P.A. (2019) Intersectin-1 interacts with the Golgin GCC88 to couple the actin network and Golgi architecture. Mol. Biol. Cell 30, 370–386 10.1091/mbc.e18-05-0313 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Paul, B.D. (2021) Signaling overlap between the Golgi stress response and cysteine metabolism in huntington's disease. Antioxidants 10, 1468 10.3390/antiox10091468 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Eisenberg-Lerner, A., Benyair, R., Hizkiahou, N., Nudel, N., Maor, R., Kramer, M.P.et al. (2020) Golgi organization is regulated by proteasomal degradation. Nat. Commun. 11, 409 10.1038/s41467-019-14038-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Sasaki, K. and Yoshida, H. (2019) Golgi stress response and organelle zones. FEBS Lett. 593, 2330–2340 10.1002/1873-3468.13554 [DOI] [PubMed] [Google Scholar]
- 70.Gao, J., Gao, A., Liu, W. and Chen, L. (2021) Golgi stress response: a regulatory mechanism of Golgi function. Biofactors 47, 964–974 10.1002/biof.1780 [DOI] [PubMed] [Google Scholar]
- 71.Makhoul, C. and Gleeson, P.A. (2021) Regulation of mTORC1 activity by the Golgi apparatus. Fac Rev. 10, 50 10.12703/r/10-50 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Carosi, J.M., Fourrier, C., Bensalem, J. and Sargeant, T.J. (2022) The mTOR–lysosome axis at the centre of ageing. FEBS Open Biol. 12, 739–757 10.1002/2211-5463.13347 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Zhang, J., Andersen, J.-P., Sun, H., Liu, X., Sonenberg, N., Nie, J.et al. (2020) Aster-C coordinates with COP I vesicles to regulate lysosomal trafficking and activation of mTORC1. EMBO Rep. 21, e49898 10.15252/embr.201949898 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Thomas, J.D., Zhang, Y.-J., Wei, Y.-H., Cho, J.-H., Morris, L.E., Wang, H.-Y.et al. (2014) Rab1a is an mTORC1 activator and a colorectal oncogene. Cancer Cell 26, 754–769 10.1016/j.ccell.2014.09.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Suzuki, Y., Ozawa, T., Kurata, T., Nakajima, N., Zamponi, G.W., Giles, W.R.et al. (2022) A molecular complex of Cav1.2/CaMKK2/CaMK1a in caveolae is responsible for vascular remodeling via excitation–transcription coupling. Proc. Natl Acad. Sci. U.S.A. 119, e2117435119 10.1073/pnas.2117435119 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Sabbir, M.G. (2018) Loss of Ca2+/calmodulin dependent protein kinase kinase 2 leads to aberrant transferrin phosphorylation and trafficking: a potential biomarker for Alzheimer's disease. Front. Mol. Biosci. 5, 99 10.3389/fmolb.2018.00099 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Dodonova, S.O., Diestelkoetter-Bachert, P., von Appen, A., Hagen, W.J.H., Beck, R., Beck, M.et al. (2015) A structure of the COPI coat and the role of coat proteins in membrane vesicle assembly. Science 349, 195–198 10.1126/science.aab1121 [DOI] [PubMed] [Google Scholar]
- 78.Hara-Kuge, S., Kuge, O., Orci, L., Amherdt, M., Ravazzola, M., Wieland, F.et al. (1994) En bloc incorporation of coatomer subunits during the assembly of COP-coated vesicles. J. Cell Biol. 124, 883–892 10.1083/jcb.124.6.883 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Lowe, M. and Kreis, T.E. (1995) In vitro assembly and disassembly of coatomer. J. Biol. Chem. 270, 31364–31371 10.1074/jbc.270.52.31364 [DOI] [PubMed] [Google Scholar]
- 80.Pavel, J., Harter, C. and Wieland, F.T. (1998) Reversible dissociation of coatomer: functional characterization of a β/δ-coat protein subcomplex. Proc. Natl Acad. Sci. U.S.A. 95, 2140–2145 10.1073/pnas.95.5.2140 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Fiedler, K., Veit, M., Stamnes, M.A. and Rothman, J.E. (1996) Bimodal interaction of coatomer with the p24 family of putative cargo receptors. Science 273, 1396–1399 10.1126/science.273.5280.1396 [DOI] [PubMed] [Google Scholar]
- 82.Bykov, Y.S., Schaffer, M., Dodonova, S.O., Albert, S., Plitzko, J.M., Baumeister, W.et al. (2017) The structure of the COPI coat determined within the cell. eLife 6, e32493 10.7554/elife.32493 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Razi, M., Chan, E.Y.W. and Tooze, S.A. (2009) Early endosomes and endosomal coatomer are required for autophagy. J. Cell Biol. 185, 305–321 10.1083/jcb.200810098 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Luzio, J.P., Hackmann, Y., Dieckmann, N.M.G. and Griffiths, G.M. (2014) The biogenesis of lysosomes and lysosome-related organelles. Cold Spring Harb. Perspect. Biol. 6, a016840 10.1101/cshperspect.a016840 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Hesketh, G.G., Wartosch, L., Davis, L.J., Bright, N.A. and Luzio, J.P. (2018) Endocytosis and signaling. Prog. Mol. Subcell. Biol. 57, 151–180 10.1007/978-3-319-96704-2_6 [DOI] [PubMed] [Google Scholar]
- 86.Ballabio, A. and Bonifacino, J.S. (2020) Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat. Rev. Mol. Cell Biol. 21, 101–118 10.1038/s41580-019-0185-4 [DOI] [PubMed] [Google Scholar]
- 87.Bouhamdani, N., Comeau, D. and Turcotte, S. (2021) A compendium of information on the lysosome. Front. Cell Dev. Biol. 9, 798262 10.3389/fcell.2021.798262 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Claerhout, S., Dutta, B., Bossuyt, W., Zhang, F., Nguyen-Charles, C., Dennison, J.B.et al. (2012) Abortive autophagy induces endoplasmic reticulum stress and cell death in cancer cells. PLoS One 7, e39400 10.1371/journal.pone.0039400 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Gasparian, A., Aksenova, M., Oliver, D., Levina, E., Doran, R., Lucius, M.et al. (2022) Depletion of COPI in cancer cells: the role of ROS in the induction of lipid accumulation, non-canonical lipophagy and apoptosis. Mol. Biol. Cell 33, ar135 10.1091/mbc.e21-08-0420 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Oliver, D., Ji, H., Liu, P., Gasparian, A., Gardiner, E., Lee, S.et al. (2017) Identification of novel cancer therapeutic targets using a designed and pooled shRNA library screen. Sci. Rep. 7, 43023–43016 10.1038/srep43023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Piccolis, M., Bond, L.M., Kampmann, M., Pulimeno, P., Chitraju, C., Jayson, C.B.K.et al. (2019) Probing the global cellular responses to lipotoxicity caused by saturated fatty acids. Mol. Cell 74, 32–44.e8 10.1016/j.molcel.2019.01.036 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Guo, Y., Walther, T.C., Rao, M., Stuurman, N., Goshima, G., Terayama, K.et al. (2008) Functional genomic screen reveals genes involved in lipid-droplet formation and utilization. Nature 453, 657–661 10.1038/nature06928 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Li, C., Luo, X., Zhao, S., Siu, G.K., Liang, Y., Chan, H.C.et al. (2017) COPI–TRAPPII activates Rab18 and regulates its lipid droplet association. EMBO J. 36, 441–457 10.15252/embj.201694866 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Soni, K.G., Mardones, G.A., Sougrat, R., Smirnova, E., Jackson, C.L. and Bonifacino, J.S. (2009) Coatomer-dependent protein delivery to lipid droplets. J. Cell Sci. 122, 1834–1841 10.1242/jcs.045849 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Frigo, D.E., Howe, M.K., Wittmann, B.M., Brunner, A.M., Cushman, I., Wang, Q.et al. (2011) Cam kinase kinase β-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells. Cancer Res. 71, 528–537 10.1158/0008-5472.can-10-2581 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Tomaszewski, W.H., Waibl-Polania, J., Chakraborty, M., Perera, J., Ratiu, J., Miggelbrink, A.et al. (2022) Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma. Nat. Commun. 13, 6483 10.1038/s41467-022-34175-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Feng, Y., Sun, C., Zhang, L., Wan, H., Zhou, H., Chen, Y.et al. (2022) Upregulation of COPB2 promotes prostate cancer proliferation and invasion through the MAPK/TGF-β signaling pathway. Front. Oncol. 12, 865317 10.3389/fonc.2022.865317 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Hu, L., Chen, X., Narwade, N., Lim, M.G.L., Chen, Z., Tennakoon, C.et al. (2021) Single-cell analysis reveals androgen receptor regulates the ER-to-Golgi trafficking pathway with CREB3L2 to drive prostate cancer progression. Oncogene 40, 6479–6493 10.1038/s41388-021-02026-7 [DOI] [PubMed] [Google Scholar]
- 99.Kim, H.S., Mendiratta, S., Kim, J., Pecot, C.V., Larsen, J.E., Zubovych, I.et al. (2013) Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer. Cell 155, 552–566 10.1016/j.cell.2013.09.041 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Giudice, S.D., Luca, V.D., Parizadeh, S., Russo, D., Luini, A. and Martino, R.D. (2022) Endogenous and exogenous regulatory signaling in the secretory pathway: role of Golgi signaling molecules in cancer. Front. Cell Dev. Biol. 10, 833663 10.3389/fcell.2022.833663 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Stork, B.A., Dean, A., Ortiz, A.R., Saha, P., Putluri, N., Planas-Silva, M.D.et al. (2022) Calcium/calmodulin-dependent protein kinase kinase 2 regulates hepatic fuel metabolism. Mol. Metab. 62, 101513 10.1016/j.molmet.2022.101513 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Pulliam, T.L., Awad, D., Han, J.J., Murray, M.M., Ackroyd, J.J., Goli, P.et al. (2022) Systemic ablation of Camkk2 impairs metastatic colonization and improves insulin sensitivity in TRAMP mice: evidence for cancer cell-extrinsic CAMKK2 functions in prostate cancer. Cells 11, 1890 10.3390/cells11121890 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Lee, A., Kondapalli, C., Virga, D.M., Lewis, T.L., Koo, S.Y., Ashok, A.et al. (2022) Aβ42 oligomers trigger synaptic loss through CAMKK2-AMPK-dependent effectors coordinating mitochondrial fission and mitophagy. Nat. Commun. 13, 4444 10.1038/s41467-022-32130-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Han, J.H., Kim, Y.K., Kim, H., Lee, J., Oh, M.J., Kim, S.B.et al. (2022) Snail acetylation by autophagy-derived acetyl-coenzyme A promotes invasion and metastasis of KRAS-LKB1 co-mutated lung cancer cells. Cancer Commun. 42, 716–749 10.1002/cac2.12332 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Profeta, G.S., Dos Reis, C.V., Santiago, A.D.S., Godoi, P.H.C., Fala, A.M., Wells, C.I.et al. (2019) Binding and structural analyses of potent inhibitors of the human Ca2+/calmodulin dependent protein kinase kinase 2 (CAMKK2) identified from a collection of commercially-available kinase inhibitors. Sci. Rep. 9, 16452 10.1038/s41598-019-52795-1 [DOI] [PMC free article] [PubMed] [Google Scholar]